The tumor microenvironment of benign and malignant salivary gland tumors

Author:

Wai Katherine C.123ORCID,Okholm Trine Line H.123,Ha Patrick K.13,Marquez Diana M.123,Tenvooren Iliana123,Jones Kyle B.12345,Spitzer Matthew H.12367

Affiliation:

1. Department of Otolaryngology – Head and Neck Surgery University of California San Francisco San Francisco California USA

2. Department of Microbiology and Immunology University of California San Francisco San Francisco California USA

3. Helen Diller Family Comprehensive Cancer Center University of California San Francisco San Francisco California USA

4. Department of Orofacial Sciences University of California San Francisco San Francisco California USA

5. Pharma Technical Cell and Gene Therapy, Genentech, Inc. South San Francisco California USA

6. Parker Institute for Cancer Immunotherapy San Francisco California USA

7. Chan Zuckerberg Biohub San Francisco California USA

Abstract

AbstractBackgroundTreatment of salivary gland tumors (SGTs) remains challenging. Little is known about the immune landscape of SGTs. We aimed to characterize the tumor microenvironment in benign and malignant SGTs.MethodsEleven benign and nine malignant tumors were collected from patients undergoing curative intent surgery. Specimens were analyzed using mass cytometry by time‐of‐flight. Immune cell populations were manually gated, and T cells were clustered using the FlowSOM algorithm. Population frequencies were compared between high‐grade and low‐grade malignancies, corrected for multiple hypothesis testing.ResultsThere were trends towards increased CD4+ and CD8+ T cells among malignant tumors. High‐grade malignancies exhibited trends towards higher frequencies of CD8+ PD‐1+ CD39+ CD103+ exhausted T cells, CD4+ FoxP3+ TCF‐1+ CD127− Tregs, and CD69+ CD25− CD4+ T cells compared to low‐grade malignancies.ConclusionSGTs exhibit significant immunologic diversity. High‐grade malignancies tended to have greater infiltration of exhausted CD8+ T cells and Tregs, which may guide future studies for immunotherapy strategies.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3